Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis | Zendy

Helen J. Lachmann | Zendy; David R. Booth | Zendy; Susanne E. Booth | Zendy; A Bybee | Zendy; Janet A. Gilbertson | Zendy; Julian D. Gillmore | Zendy; Mark B. Pepys | Zendy; Philip N. Hawkins | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis

Author(s) -

Helen J. Lachmann,

David R. Booth,

Susanne E. Booth,

A Bybee,

Janet A. Gilbertson,

Julian D. Gillmore,

Mark B. Pepys,

Philip N. Hawkins

Publication year - 2002

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa013354

Subject(s) - amyloidosis , medicine , transthyretin , amyloid (mycology) , differential diagnosis , al amyloidosis , polyneuropathy , pathology , fibrinogen , gammopathy , gastroenterology , immunology , immunoglobulin light chain , monoclonal , antibody , monoclonal antibody

Hereditary, autosomal dominant amyloidosis, caused by mutations in the genes encoding transthyretin, fibrinogen A alpha-chain, lysozyme, or apolipoprotein A-I, is thought to be extremely rare and is not routinely included in the differential diagnosis of systemic amyloidosis unless there is a family history.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research